Rockwell Medical, Inc. (RMTI)
Evaluation: Based on all recent filings, financial statements, and news.
See full evaluationAsk a question about Rockwell Medical, Inc. (RMTI)
Go deeper and ask any question about RMTI
Company Performance
Current Price
as of Oct 03, 2024$3.56
P/E Ratio
N/A
Market Cap
$110.47M
Description
Rockwell Medical, Inc. is a biopharmaceutical company, which engages in the development of treatment for anemia, kidney disease, iron deficiency, and hemodialysis. Its products include Triferic, CitraPure, RenalPure and SteriLyte. The company was founded by Robert L. Chioini in 1996 and is headquartered in Wixom, MI.
Metrics
Overview
- HQWixom, MI
- SectorHealth Technology
- IndustryMedical Specialties
- TickerRMTI
- Price$3.56-2.20%
Trading Information
- Market Cap$110.47M
- Float88.41%
- Average Daily Volume (1m)764,915
- Average Daily Volume (3m)476,611
- EPS-$0.17
Company
- Revenue$94.37M
- Rev Growth (1yr)42.88%
- Net Income$0.29M
- Gross Margin17.61%
- EBITDA Margin4.12%
- EBITDA$1.06M
- EV$58.89M
- EV/Revenue0.62
- P/EN/A
- P/S1.21
Documents
SEC Filings
Earnings Calls
Factset Street Account